{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:04:52Z","timestamp":1792598692487,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Caffeine exposure modifies the turnover of monoamine neurotransmitters, which play a role in several neuropsychiatric disorders. We conducted a Mendelian randomization study to investigate whether higher plasma caffeine levels are causally associated with the risk of anorexia nervosa, bipolar disorder, major depressive disorder (MDD), and schizophrenia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Summary-level data on the neuropsychiatric disorders were obtained from large-scale genome-wide association studies (GWASs) of European ancestry participants (<jats:italic>n<\/jats:italic>\u2009=\u200972,517 to 807,553) and meta-analyzed with the corresponding data from the FinnGen study (<jats:italic>n<\/jats:italic>\u2009=\u2009356,077). Summary-level data on plasma caffeine were extracted from a GWAS meta-analysis of 9876 European ancestry individuals. The Mendelian randomization analyses estimated the Wald ratio for each genetic variant and meta-analyzed the variant-specific estimates using multiplicative random effects meta-analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After correcting for multiple testing, genetically predicted higher plasma caffeine levels were associated with higher odds of anorexia nervosa (odds ratio [OR]\u2009=\u20091.124; 95% confidence interval [CI]\u2009=\u20091.024\u20131.238, <jats:italic>p<\/jats:italic><jats:sub>FDR<\/jats:sub>\u2009=\u20090.039) and a lower odds of bipolar disorder (OR\u2009=\u20090.905, 95% CI\u2009=\u20090.827\u20130.929, <jats:italic>p<\/jats:italic><jats:sub>FDR<\/jats:sub>\u2009=\u20090.041) and MDD (OR\u2009=\u20090.965, 95% CI\u2009=\u20090.937\u20130.995, <jats:italic>p<\/jats:italic><jats:sub>FDR<\/jats:sub>\u2009=\u20090.039). Instrumented plasma caffeine levels were not associated with schizophrenia (OR\u2009=\u20090.986, 95% CI\u2009=\u20090.929\u20131.047, <jats:italic>p<\/jats:italic><jats:sub>FDR<\/jats:sub>\u2009=\u20090.646).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These Mendelian randomization findings indicate that long-term higher plasma caffeine levels may lower the risk of bipolar disorder and MDD but increase the risk of anorexia nervosa. These results warrant further research to explore whether caffeine consumption, supplementation, or abstinence could render clinically relevant therapeutic or preventative psychiatric effects.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-023-03008-0","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T10:02:24Z","timestamp":1691488944000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Appraising the causal relationship between plasma caffeine levels and neuropsychiatric disorders through Mendelian randomization"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1505-2570","authenticated-orcid":false,"given":"Benjamin","family":"Woolf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6855-8324","authenticated-orcid":false,"given":"H\u00e9l\u00e9ne T.","family":"Cronj\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7700-8102","authenticated-orcid":false,"given":"Loukas","family":"Zagkos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5365-8760","authenticated-orcid":false,"given":"Stephen","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7312-7078","authenticated-orcid":false,"given":"Dipender","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0118-0341","authenticated-orcid":false,"given":"Susanna C.","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,8]]},"reference":[{"issue":"1","key":"3008_CR1","first-page":"83","volume":"51","author":"BB Fredholm","year":"1999","unstructured":"Fredholm BB, B\u00e4ttig K, Holm\u00e9n J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev. 1999;51(1):83\u2013133.","journal-title":"Pharmacol Rev"},{"issue":"3","key":"3008_CR2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1080\/j.1440-1614.2005.01536.x","volume":"39","author":"P Bosanac","year":"2005","unstructured":"Bosanac P, Norman T, Burrows G, Beumont P. Serotonergic and dopaminergic systems in anorexia nervosa: a role for atypical antipsychotics? Aust N Z J Psychiatry. 2005;39(3):146\u201353.","journal-title":"Aust N Z J Psychiatry"},{"key":"3008_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1146\/annurev.clinpsy.2.022305.095332","volume":"2","author":"DJ Miklowitz","year":"2006","unstructured":"Miklowitz DJ, Johnson SL. The psychopathology and treatment of bipolar disorder. Annu Rev Clin Psychol. 2006;2:199\u2013235.","journal-title":"Annu Rev Clin Psychol"},{"issue":"1","key":"3008_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1055\/s-2007-979535","volume":"29","author":"GR Heninger","year":"1996","unstructured":"Heninger GR, Delgado PL, Charney DS. The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans. Pharmacopsychiatry. 1996;29(1):2\u201311.","journal-title":"Pharmacopsychiatry"},{"key":"3008_CR5","first-page":"47","volume":"5","author":"R Brisch","year":"2014","unstructured":"Brisch R, Saniotis A, Wolf R, Bielau H, Bernstein HG, Steiner J, et al. The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue. Front Psychiatry. 2014;5:47.","journal-title":"Front Psychiatry"},{"key":"3008_CR6","doi-asserted-by":"publisher","first-page":"1037579","DOI":"10.3389\/fpsyt.2022.1037579","volume":"13","author":"J Bao","year":"2022","unstructured":"Bao J, Li P, Guo Y, Zheng Y, Smolinski M, He J. Caffeine is negatively associated with depression in patients aged 20 and older. Front Psychiatry. 2022;13:1037579.","journal-title":"Front Psychiatry"},{"key":"3008_CR7","doi-asserted-by":"crossref","unstructured":"Torabynasab K, Shahinfar H, Payandeh N, Jazayeri S. Association between dietary caffeine, coffee, and tea consumption and depressive symptoms in adults: a systematic review and dose-response meta-analysis of observational studies. Front Nutr. 2023;10:1051444.","DOI":"10.3389\/fnut.2023.1051444"},{"key":"3008_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.schres.2019.07.026","volume":"211","author":"M Topyurek","year":"2019","unstructured":"Topyurek M, Tibbo P, N\u00fa\u00f1ez C, Stephan-Otto C, Good K. Caffeine effects and schizophrenia: is there a need for more research? Schizophr Res. 2019;211:34\u20135.","journal-title":"Schizophr Res"},{"issue":"24","key":"3008_CR9","first-page":"5472","volume":"25","author":"MC Cornelis","year":"2016","unstructured":"Cornelis MC, Kacprowski T, Menni C, Gustafsson S, Pivin E, Adamski J, et al. Genome-wide association study of caffeine metabolites provides new insights to caffeine metabolism and dietary caffeine-consumption behavior. Hum Mol Genet. 2016;25(24):5472\u201382.","journal-title":"Hum Mol Genet"},{"issue":"7906","key":"3008_CR10","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/s41586-022-04434-5","volume":"604","author":"V Trubetskoy","year":"2022","unstructured":"Trubetskoy V, Panagiotaropoulou G, Awasthi S, Braun A, Kraft J, Skarabis N, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022;604(7906):502\u20138.","journal-title":"Nature"},{"issue":"9","key":"3008_CR11","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/s41467-018-03819-3","volume":"16","author":"DM Howard","year":"2018","unstructured":"Howard DM, Adams MJ, Shirali M, Clarke TK, Marioni RE, Davies G, et al. Genome-wide association study of depression phenotypes in UK Biobank identifies variants in excitatory synaptic pathways. Nat Commun. 2018;16(9):1470.","journal-title":"Nat Commun"},{"key":"3008_CR12","unstructured":"Risteys FinnGen R6 - I9_CVD. https:\/\/r6.risteys.finngen.fi\/phenocode\/I9_CVD. [cited 2022 Apr 6]."},{"issue":"8","key":"3008_CR13","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/s41588-022-01124-w","volume":"54","author":"K Watanabe","year":"2022","unstructured":"Watanabe K, Jansen PR, Savage JE, Nandakumar P, Wang X, Hinds DA, et al. Genome-wide meta-analysis of insomnia prioritizes genes associated with metabolic and psychiatric pathways. Nat Genet. 2022;54(8):1125\u201332.","journal-title":"Nat Genet"},{"issue":"8","key":"3008_CR14","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/s41588-019-0439-2","volume":"51","author":"HJ Watson","year":"2019","unstructured":"Watson HJ, Yilmaz Z, Thornton LM, H\u00fcbel C, Coleman JR, Gaspar HA, et al. Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa. Nat Genet. 2019;51(8):1207\u201314.","journal-title":"Nat Genet"},{"key":"3008_CR15","doi-asserted-by":"publisher","unstructured":"Cornelis MC. caff_share.gz (v1.0.0). DigitalHub. Galter Health Sciences Library. 2016. https:\/\/doi.org\/10.18131\/G3860C.","DOI":"10.18131\/G3860C"},{"key":"3008_CR16","unstructured":"Download Results \u2013 PGC. https:\/\/pgc.unc.edu\/for-researchers\/download-results\/. [cited 2023 Jul 26]."},{"issue":"6","key":"3008_CR17","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41588-021-00857-4","volume":"53","author":"N Mullins","year":"2021","unstructured":"Mullins N, Forstner AJ, O\u2019Connell KS, Coombes B, Coleman JRI, Qiao Z, et al. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. Nat Genet. 2021;53(6):817\u201329.","journal-title":"Nat Genet"},{"key":"3008_CR18","doi-asserted-by":"crossref","unstructured":"Elsworth B, Lyon M, Alexander T, Liu Y, Matthews P, Hallett J, et al. The MRC IEU OpenGWAS data infrastructure. bioRxiv. 2020.08.10.244293.","DOI":"10.1101\/2020.08.10.244293"},{"key":"3008_CR19","unstructured":"Trait: Major depression - IEU OpenGWAS project https:\/\/gwas.mrcieu.ac.uk\/datasets\/ieu-b-102\/. [cited 2023 Jul 26]."},{"key":"3008_CR20","unstructured":"FinnGen. FinnGen Documentation of R5 release. 2021. https:\/\/finngen.gitbook.io\/documentation\/v\/r5\/."},{"key":"3008_CR21","unstructured":"Kurki MI, Karjalainen J, Palta P, Sipil\u00e4 TP, Kristiansson K, Donner K, et al. FinnGen: unique genetic insights from combining isolated population and national health register data. medRxiv. 2022. 2022.03.03.22271360."},{"key":"3008_CR22","unstructured":"Access results | FinnGen https:\/\/www.finngen.fi\/en\/access_results [cited 2023 Jul 26]."},{"key":"3008_CR23","doi-asserted-by":"crossref","unstructured":"Larsson SC, Woolf B, Gill D. Appraisal of the causal effect of plasma caffeine on adiposity, type 2 diabetes, and cardiovascular disease: two sample mendelian randomisation study. BMJ Med. 2023;2(1):1\u20138.","DOI":"10.1136\/bmjmed-2022-000335"},{"issue":"9","key":"3008_CR24","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.3390\/nu14091697","volume":"14","author":"SC Larsson","year":"2022","unstructured":"Larsson SC, Woolf B, Gill D. Plasma caffeine levels and risk of Alzheimer\u2019s disease and Parkinson\u2019s disease: Mendelian randomization study. Nutrients. 2022;14(9):1697.","journal-title":"Nutrients"},{"key":"3008_CR25","unstructured":"R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computin. 2021. https:\/\/www.R-project.org\/."},{"key":"3008_CR26","doi-asserted-by":"crossref","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife. 2018;7:e34408.","DOI":"10.7554\/eLife.34408"},{"key":"3008_CR27","doi-asserted-by":"crossref","unstructured":"Bigdeli TB, Lee D, Riley BP, Vladimirov V, Fanous AH, Kendler KS, et al. FIQT: a simple, powerful method to accurately estimate effect sizes in genome scans. bioRxiv. 2015.019299.","DOI":"10.1101\/019299"},{"issue":"8","key":"3008_CR28","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/gepi.22077","volume":"41","author":"S Burgess","year":"2017","unstructured":"Burgess S, Zuber V, Valdes-Marquez E, Sun BB, Hopewell JC. Mendelian randomization with fine-mapped genetic data: choosing from large numbers of correlated instrumental variables. Genet Epidemiol. 2017;41(8):714\u201325.","journal-title":"Genet Epidemiol"},{"issue":"12","key":"3008_CR29","first-page":"2681","volume":"187","author":"J Bowden","year":"2018","unstructured":"Bowden J, Hemani G, Davey SG. Invited commentary: detecting individual and global horizontal pleiotropy in Mendelian randomization\u2014a job for the humble heterogeneity statistic? Am J Epidemiol. 2018;187(12):2681\u20135.","journal-title":"Am J Epidemiol"},{"key":"3008_CR30","doi-asserted-by":"crossref","unstructured":"Labrecque JA, Swanson SA. Interpretation and potential biases of Mendelian randomization estimates with time-varying exposures. Am J Epidemiol. 2019;188(1):231\u20138.","DOI":"10.1093\/aje\/kwy204"},{"key":"3008_CR31","doi-asserted-by":"crossref","unstructured":"Woolf B, Cronj\u00e9 HT, Zagkos L, Larsson SC, Gill D, Burgess S. Comparison of caffeine consumption behavior with plasma caffeine levels as exposures in drug-target Mendelian randomization and implications for interpreting effects on obesity. medRxiv. 2023.05.30.23290752.","DOI":"10.1101\/2023.05.30.23290752"},{"issue":"5","key":"3008_CR32","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1093\/ije\/dyaa266","volume":"50","author":"FP Hartwig","year":"2021","unstructured":"Hartwig FP, Tilling K, Davey Smith G, Lawlor DA, Borges MC. Bias in two-sample Mendelian randomization when using heritable covariable-adjusted summary associations. Int J Epidemiol. 2021;50(5):1639\u201350.","journal-title":"Int J Epidemiol"},{"issue":"8","key":"3008_CR33","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/sim.3034","volume":"27","author":"DA Lawlor","year":"2008","unstructured":"Lawlor DA, Harbord RM, Sterne JAC, Timpson N, Davey SG. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27(8):1133\u201363.","journal-title":"Stat Med"},{"issue":"4","key":"3008_CR34","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1177\/0962280206077743","volume":"16","author":"V Didelez","year":"2007","unstructured":"Didelez V, Sheehan N. Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res. 2007;16(4):309\u201330.","journal-title":"Stat Methods Med Res"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-03008-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-023-03008-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-03008-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T12:14:59Z","timestamp":1700568899000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-023-03008-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,8]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3008"],"URL":"https:\/\/doi.org\/10.1186\/s12916-023-03008-0","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,8]]},"assertion":[{"value":"5 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Studies included in the published GWAS meta-analyses and the FinnGen study were approved by the relevant ethical review authority, and voluntary informed consent was obtained from participants. This study only analyzed publicly available summary-level statistical data. Therefore, no new ethical review board approval was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DG is employed part-time by Novo Nordisk. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"296"}}